Yes, Lyrica (pregabalin) is classified as an anticonvulsant, also called an antiepileptic drug. The FDA approved it as an add-on therapy for partial onset seizures in adults, meaning it’s used alongside other seizure medications rather than on its own. But Lyrica is equally well known for treating nerve pain and fibromyalgia, which is why many people aren’t sure of its original drug class.
How Lyrica Works as an Anticonvulsant
Pregabalin binds to a specific part of voltage-gated calcium channels in the brain and spinal cord, called the alpha-2-delta type 1 subunit. In practical terms, this binding reduces the release of excitatory chemical signals between nerve cells. When neurons fire less aggressively, seizure activity becomes less likely to spread through the brain.
This same mechanism is what makes the drug useful for nerve pain and anxiety disorders. By calming overexcited nerve signaling, pregabalin addresses seizures, neuropathic pain, and fibromyalgia through a single pathway. The drug doesn’t switch between different modes depending on the condition. It does one thing, and that one thing happens to help in several situations.
Its Role in Seizure Treatment
Lyrica is specifically approved to treat partial onset seizures, the most common seizure type in adults. These seizures start in one area of the brain and may or may not spread. The drug is not used alone for seizures. Instead, it’s added to an existing medication regimen when current drugs aren’t providing enough control.
In clinical trials, the results were significant. Patients taking pregabalin three times daily saw seizure frequency drop by 53%, compared to a 1% increase in the placebo group. The median reduction was about 48% for those on the three-times-daily schedule. Nearly half of patients on that regimen (49%) qualified as “responders,” meaning their seizures decreased by at least 50%, versus just 9% on placebo. A twice-daily schedule also worked, though slightly less effectively, with a 44% reduction in seizure frequency.
Why It’s Also a Controlled Substance
Lyrica is a Schedule V controlled substance under federal law, the lowest level of restriction. The DEA placed it in this category in 2005 after finding that it has a low potential for abuse but can produce euphoria, drowsiness, and other effects that some people seek out recreationally. In clinical trials, an unusually high percentage of participants reported euphoric effects. Other common side effects include dizziness, blurred vision, weight gain, and swelling in the hands or feet.
Schedule V means your prescription may have refill limits or require identification at the pharmacy, depending on state law. It’s a lower level of control than drugs like benzodiazepines (Schedule IV) or opioids (Schedule II).
Dosing for Seizures
For epilepsy in adults, the typical starting dose is 150 mg per day, divided into two or three doses. The maximum is 600 mg per day. Your doctor will usually increase the dose gradually based on how well your seizures respond and how you tolerate side effects. For children weighing 30 kg (about 66 pounds) or more, dosing follows a similar structure with the same 600 mg ceiling. Smaller children are dosed by body weight, up to 14 mg per kg per day.
Combining Lyrica With Other Seizure Drugs
One of Lyrica’s practical advantages is that it plays well with other anticonvulsants. Studies have confirmed that pregabalin does not change the blood levels of four commonly used seizure medications: carbamazepine, phenytoin, lamotrigine, and valproate. Those drugs don’t alter pregabalin levels either. This means doctors can add Lyrica to an existing seizure regimen without worrying about one drug weakening or amplifying another, a problem that complicates many other anticonvulsant combinations.
Risks of Stopping Suddenly
If you’ve been taking Lyrica for seizures (or for any reason), stopping abruptly can cause withdrawal symptoms including insomnia, headache, nausea, anxiety, diarrhea, and dizziness. More seriously, sudden cessation can trigger seizures, even in people who weren’t originally taking the drug for epilepsy. When pregabalin is removed suddenly, the nerve-calming effect disappears and excitatory signaling can rebound sharply.
The recommended approach is to taper off over at least one week. Your prescriber will typically reduce the dose in steps rather than cutting it off all at once. This is especially important for people with kidney problems, since the drug clears the body more slowly in that population and withdrawal effects can be more pronounced.